Ctxr analysis
WebDawson James analyst Jason Kolbert maintained a Buy rating on Citius Pharmaceuticals (CTXR - Research Report) on September 28 and set a price target of $10.00. The … WebApr 10, 2024 · Albemarle. Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. View Full Analysis. Rewards. Trading at 42.2% below our estimate of its fair value. Revenue is forecast to grow 9.19% per year. Earnings grew by 2075% over the past year.
Ctxr analysis
Did you know?
WebApr 13, 2024 · CTXR Stock Price Performance Analysis Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. Until today this year the stock’s price performance recorded an increase of 98.73%. WebSee Citius Pharmaceuticals, Inc. (CTXR) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.
WebCTXR 2M Long Term test Citius Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the development and commercialization of critical care products, with a … WebApr 10, 2024 · While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Even so, be aware that American Electric Power Company is showing 3 warning signs in our investment analysis, and 1 of those is a bit unpleasant...
WebThe 3 analysts offering 12-month price forecasts for Citius Pharmaceuticals Inc have a median target of 6.00, with a high estimate of 10.00 and a low estimate of 4.00. The … WebCTXR technical analysis Your technical analysis summary for Citius Pharmaceuticals, Inc This gauge displays a real-time technical analysis overview for your selected timeframe. The summary of Citius Pharmaceuticals, Inc is based on the most popular technical indicators, such as Moving Averages, Oscillators and Pivots. Learn more . 1 minute
Web1 day ago · Ticker Symbol CTXR Full Company Profile Financial Performance Financial Statements Analyst Forecast According to 9 analysts, the average rating for CTXR stock …
WebBased on analysts offering 12 month price targets for CTXR in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . pool toy for dogsWebThe Citius Pharmaceuticals stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, … pool toy inflator nozzleWebThe current Citius Pharmaceuticals [ CTXR] share price is $1.16. The Score for CTXR is 52, which is 4% above its historic median score of 50, and infers lower risk than normal. CTXR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels. shared_ptr std::threadWebApr 11, 2024 · Stock Price Forecast. According to 8 stock analysts, the average 12-month stock price forecast for CTXR stock is $ 7.14 , which predicts an increase of 510.26%. … shared ptr swapWeb106 rows · In this section, we analyze the profitability of every unplanned, open-market insider purchase made in CTXR / Citius Pharmaceuticals Inc. This analysis helps to understand if the insider consistently generates … pool toy mesh storage bagWebApr 13, 2024 · According to the data, the short interest in Citius Pharmaceuticals Inc. (CTXR) stood at 7.83% of shares outstanding as of Mar 14, 2024; the number of short shares registered in Feb 14, 2024 reached 10.97 million. The stock has risen by 98.73% since the beginning of the year, thereby showing the potential of a further growth. shared_ptr uint8WebMar 30, 2024 · Live In Play®. Updated: 30-Mar-23 08:33 ET. CTXR: Citius Pharmaceuticals advances efforts to spin off oncology asset, I/ONTAK, into a standalone public company (1.10) Co announced that Maxim Group LLC will serve as financial advisor to its wholly-owned subsidiary, Citius Acquisition Corp. Inc., in connection with the intended formation … shared_ptr weak_ptr unique_ptr